Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Thrombophilia D019851 6 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Ozaki Y et al. A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway. 1986 Biochem. Pharmacol. pmid:3021173
Vanhoutte PM et al. Modulation of vascular smooth muscle contraction by the endothelium. 1986 Annu. Rev. Physiol. pmid:2871807
Handley DA et al. Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist. 1986 Immunopharmacology pmid:3019921
Suemune H et al. Enzymatic synthesis of 2,3-O-isopropylidene-sn-glycerol, a chiral building block for platelet-activating factor. 1986 Chem. Pharm. Bull. pmid:3791517
Silva PM et al. Platelet involvement in rat paw edema induced by 2-methoxy-PAF. 1986 Inflammation pmid:3793206
Wu MS et al. Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist. 1986 J. Pharmacol. Exp. Ther. pmid:3795043
Tetta C et al. Platelet-activating factor contracts human myometrium in vitro. 1986 Proc. Soc. Exp. Biol. Med. pmid:3797421
Montrucchio G et al. In vitro contractile effect of platelet-activating factor on guinea-pig myometrium. 1986 Prostaglandins pmid:3797692
Bourgain RH et al. Vivo effects of PAF-acether and arterial thrombosis. 1986 Adv. Exp. Med. Biol. pmid:3799334
Kloprogge E et al. PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy. 1986 Biochem. J. pmid:3800968
Desquand S et al. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig. 1986 Eur. J. Pharmacol. pmid:3019727
Daniel LW et al. A novel mechanism of diglyceride formation. 12-O-tetradecanoylphorbol-13-acetate stimulates the cyclic breakdown and resynthesis of phosphatidylcholine. 1986 J. Biol. Chem. pmid:3087989
Ohno M et al. Molecular design toward biologically significant compounds based on platelet activating factor: a highly selective agonist as a potential antihypertensive agent. 1986 J. Med. Chem. pmid:3761300
Parnham MJ and Bittner C Pharmacological analysis of guinea-pig macrophage chemiluminescence responses to platelet activating factor and opsonized zymosan. 1986 Int. J. Immunopharmacol. pmid:3804536
Adnot S et al. Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig. 1986 Prostaglandins pmid:3562865
Malavasi F et al. Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes. 1986 Proc. Natl. Acad. Sci. U.S.A. pmid:3085094
Orozco C et al. Platelet-activating factor induces the expression of early pregnancy factor activity in female mice. 1986 J. Reprod. Fertil. pmid:3806515
Wissner A et al. Analogues of platelet activating factor. 5. Multiple oxygen substitution of the alkoxy chain. 1986 J. Med. Chem. pmid:3806583
Kloprogge E et al. Stimulus-aggregation coupling in platelets activated with PAF-acether. 1986 Biochim. Biophys. Acta pmid:3089297
Doebber TW et al. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731. 1986 J. Immunol. pmid:3011900
McManus LM Pathobiology of platelet-activating factors. 1986 Pathol Immunopathol Res pmid:3543915
Tokumura A et al. Alkylacetylglycerophosphocholine effects on the metabolism of phospholipids in rabbit platelets: effects of extracellular Ca2+ and prostacyclin. 1986 Arch. Biochem. Biophys. pmid:3013094
Houslay MD et al. Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni. 1986 Biochem. J. pmid:3013161
Fechter M et al. Experimental eosinophilia and inflammation--the effect of various inflammatory mediators and chemoattractants. 1986 Exp Pathol pmid:3013671
Fisher RA et al. Effects of beta-adrenergic stimulation on 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine-mediated vasoconstriction and glycogenolysis in the perfused rat liver. 1986 J. Biol. Chem. pmid:3013865
Darius H et al. Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonists. 1986 Int. Arch. Allergy Appl. Immunol. pmid:3015804
Kloprogge E et al. Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets. 1986 J. Biol. Chem. pmid:3015954
Coëffier E et al. Transient activation of the acetyltransferase necessary for paf-acether biosynthesis in thrombin-activated platelets. 1986 Br. J. Haematol. pmid:3964558
Raaijmakers JA et al. Phospholipase A2 products induce pulmonary beta-adrenoceptor deviations. 1986 Eur. J. Pharmacol. pmid:3019725
Bachelet M et al. Changes induced by PAF-acether in diacyl and ether phospholipids from guinea-pig alveolar macrophages. 1986 Biochim. Biophys. Acta pmid:3092866
Alonso F et al. A cytosolic phospholipase in human neutrophils that hydrolyzes arachidonoyl-containing phosphatidylcholine. 1986 Biochim. Biophys. Acta pmid:3092867
Guinot P et al. Inhibition of PAF-acether induced weal and flare reaction in man by a specific PAF antagonist. 1986 Prostaglandins pmid:3763944
Scherf H et al. Hemodynamic effects of platelet activating factor in the dog kidney in vivo. 1986 Hypertension pmid:3744467
Bussolino F et al. Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy. 1986 Acta Haematol. pmid:3019063
McKean ML et al. Formation of diacyl- and alkylacylphosphatidylcholine by the membranes of human platelets. 1986 FEBS Lett. pmid:3943622
Dewald B and Baggiolini M Platelet-activating factor as a stimulus of exocytosis in human neutrophils. 1986 Biochim. Biophys. Acta pmid:3017443
Wallace JL and Whittle BJ Effects of inhibitors of arachidonic acid metabolism on Paf-induced gastric mucosal necrosis and haemoconcentration. 1986 Br. J. Pharmacol. pmid:3096408
Kester M et al. Alkylacetylglycerophosphocholine stimulates Na+-Ca2+ exchange, protein phosphorylation and polyphosphoinositide turnover in rat ileal plasmalemmal vesicles. 1986 Biochim. Biophys. Acta pmid:3019423
Voelkel NF et al. PAF antagonists: different effects on platelets, neutrophils, guinea pig ileum and PAF-induced vasodilation in isolated rat lung. 1986 Prostaglandins pmid:3024235
Zimmerman GA et al. Thrombin stimulates neutrophil adherence by an endothelial cell-dependent mechanism: characterization of the response and relationship to platelet-activating factor synthesis. 1986 Ann. N. Y. Acad. Sci. pmid:3471149
Küster LJ and Frölich JC Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man. 1986 Prostaglandins pmid:3097760
Etienne A et al. The relative role of PAF-acether and icosanoids in septic shock. 1986 Pharmacol Res Commun pmid:3774851
Maes L et al. Endogenic PAF-acether production by guinea pig endothelial cells in experimental arterial thrombosis. 1986 Pharmacol Res Commun pmid:3774852
Handley DA et al. Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI 63-441. 1986 Thromb. Haemost. pmid:3775689
Hwang SB and Lam MH Species difference in the specific receptors of platelet activating factor. 1986 Biochem. Pharmacol. pmid:3024653
Han GQ et al. [Neolignans from Piper hancei Maxim]. 1986 Yao Xue Xue Bao pmid:3776545
Koltai M et al. Effect of BN 52021, a specific PAF-acether antagonist, on cardiac anaphylaxis in Langendorff hearts isolated from passively sensitized guinea-pigs. 1986 Eur. J. Pharmacol. pmid:3780855
Montrucchio G et al. Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist. 1986 Int J Tissue React pmid:3025124
Salari H Solid-phase extraction and reversed-phase high-performance liquid chromatographic technique for isolation and estimation of platelet activating factor in plasma. 1986 J. Chromatogr. pmid:3782417
Ng DS and Wong K GTP regulation of platelet-activating factor binding to human neutrophil membranes. 1986 Biochem. Biophys. Res. Commun. pmid:3026378